- Home
- INAB vs SYNX Comparison
INAB vs SYNX Comparison
Compare INAB & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- SYNX
- Stock Information
- Founded
- INAB 2016
- SYNX 2005
- Country
- INAB United States
- SYNX Israel
- Employees
- INAB N/A
- SYNX N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- SYNX
- Sector
- INAB Health Care
- SYNX
- Exchange
- INAB Nasdaq
- SYNX Nasdaq
- Market Cap
- INAB 18.8M
- SYNX 20.8M
- IPO Year
- INAB 2021
- SYNX 2024
- Fundamental
- Price
- INAB $0.27
- SYNX $3.85
- Analyst Decision
- INAB Strong Buy
- SYNX
- Analyst Count
- INAB 3
- SYNX 0
- Target Price
- INAB $5.57
- SYNX N/A
- AVG Volume (30 Days)
- INAB 14.2M
- SYNX 3.2K
- Earning Date
- INAB 03-13-2025
- SYNX 10-02-2024
- Dividend Yield
- INAB N/A
- SYNX N/A
- EPS Growth
- INAB N/A
- SYNX N/A
- EPS
- INAB N/A
- SYNX N/A
- Revenue
- INAB N/A
- SYNX $9,893,000.00
- Revenue This Year
- INAB N/A
- SYNX $52.34
- Revenue Next Year
- INAB N/A
- SYNX N/A
- P/E Ratio
- INAB N/A
- SYNX N/A
- Revenue Growth
- INAB N/A
- SYNX 18.05
- 52 Week Low
- INAB $0.22
- SYNX $2.10
- 52 Week High
- INAB $1.74
- SYNX $6.49
- Technical
- Relative Strength Index (RSI)
- INAB 47.53
- SYNX 45.82
- Support Level
- INAB $0.25
- SYNX $3.60
- Resistance Level
- INAB $0.30
- SYNX $4.10
- Average True Range (ATR)
- INAB 0.04
- SYNX 0.26
- MACD
- INAB 0.00
- SYNX -0.04
- Stochastic Oscillator
- INAB 19.95
- SYNX 47.59
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.